BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1149 related articles for article (PubMed ID: 26503843)

  • 1. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial.
    Razavi Zade M; Telkabadi MH; Bahmani F; Salehi B; Farshbaf S; Asemi Z
    Liver Int; 2016 Apr; 36(4):563-71. PubMed ID: 26503843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of DASH diet on lipid profiles and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized clinical trial.
    Asemi Z; Samimi M; Tabassi Z; Shakeri H; Sabihi SS; Esmaillzadeh A
    Nutrition; 2014; 30(11-12):1287-93. PubMed ID: 25194966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled clinical trial investigating the effect of DASH diet on insulin resistance, inflammation, and oxidative stress in gestational diabetes.
    Asemi Z; Samimi M; Tabassi Z; Sabihi SS; Esmaillzadeh A
    Nutrition; 2013 Apr; 29(4):619-24. PubMed ID: 23466048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DASH diet, insulin resistance, and serum hs-CRP in polycystic ovary syndrome: a randomized controlled clinical trial.
    Asemi Z; Esmaillzadeh A
    Horm Metab Res; 2015 Mar; 47(3):232-8. PubMed ID: 24956415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
    Daneshi-Maskooni M; Keshavarz SA; Mansouri S; Qorbani M; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    Trials; 2017 Jun; 18(1):260. PubMed ID: 28592311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Dietary Approach to Stop Hypertension diet on androgens, antioxidant status and body composition in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial.
    Azadi-Yazdi M; Karimi-Zarchi M; Salehi-Abargouei A; Fallahzadeh H; Nadjarzadeh A
    J Hum Nutr Diet; 2017 Jun; 30(3):275-283. PubMed ID: 28466507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a high monounsaturated vs high polyunsaturated fat hypocaloric diets in nonalcoholic fatty liver disease.
    Aller R; de Luis DA; Izaola O; de la Fuente B; Bachiller R
    Eur Rev Med Pharmacol Sci; 2014; 18(7):1041-7. PubMed ID: 24763885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: A parallel randomized trial.
    Kani AH; Alavian SM; Esmaillzadeh A; Adibi P; Azadbakht L
    Nutrition; 2014; 30(7-8):814-21. PubMed ID: 24984998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of dietary approaches to stop hypertension diet on weight loss, anti-Müllerian hormone and metabolic profiles in women with polycystic ovary syndrome: A randomized clinical trial.
    Foroozanfard F; Rafiei H; Samimi M; Gilasi HR; Gorjizadeh R; Heidar Z; Asemi Z
    Clin Endocrinol (Oxf); 2017 Jul; 87(1):51-58. PubMed ID: 28316072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a high-protein diet with β-cryptoxanthin supplementation on metabolic risk factors, oxidative and inflammatory biomarkers in non-alcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled clinical trial.
    Haidari F; Hojhabrimanesh A; Helli B; Seyedian SS; Ahmadi-Angali K
    Trials; 2018 Nov; 19(1):634. PubMed ID: 30445988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
    Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
    Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recommendations to follow the Dietary Approaches to Stop Hypertension (DASH) diet v. usual dietary advice on childhood metabolic syndrome: a randomised cross-over clinical trial.
    Saneei P; Hashemipour M; Kelishadi R; Rajaei S; Esmaillzadeh A
    Br J Nutr; 2013 Dec; 110(12):2250-9. PubMed ID: 23773316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.
    Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.
    Abd El-Kader SM; Al-Shreef FM; Al-Jiffri OH
    Afr Health Sci; 2016 Mar; 16(1):242-9. PubMed ID: 27358638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents.
    de Piano A; de Mello MT; Sanches Pde L; da Silva PL; Campos RM; Carnier J; Corgosinho F; Foschini D; Masquio DL; Tock L; Oyama LM; do Nascimento CM; Tufik S; Dâmaso AR
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1313-24. PubMed ID: 22932160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on the Metabolic Side Effects of Corticosteroid Medications.
    Azadbakht L; Izadi V; Ehsani S; Esmaillzadeh A
    J Am Coll Nutr; 2016; 35(4):285-90. PubMed ID: 26650562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of two different hypocaloric diets in transaminases and insulin resistance in nonalcoholic fatty liver disease and obese patients.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R
    Nutr Hosp; 2010; 25(5):730-5. PubMed ID: 21336428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to the Dietary Approaches to Stop Hypertension (DASH) diet is associated with lower presence of non-alcoholic fatty liver disease in middle-aged and elderly adults.
    Xiao ML; Lin JS; Li YH; Liu M; Deng YY; Wang CY; Chen YM
    Public Health Nutr; 2020 Mar; 23(4):674-682. PubMed ID: 31566148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moderate replacement of carbohydrates by dietary fats affects features of metabolic syndrome: a randomized crossover clinical trial.
    Rajaie S; Azadbakht L; Khazaei M; Sherbafchi M; Esmaillzadeh A
    Nutrition; 2014 Jan; 30(1):61-8. PubMed ID: 24290600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.